Lv31
270 积分 2023-09-13 加入
Targeting IL-1α in cancer cachexia: a narrative review
5天前
已完结
Daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone alone in previously treated multiple myeloma (APOLLO): an open-label, randomised, phase 3 trial
14天前
已完结
Linvoseltamab (LINVO) + carfilzomib (CFZ) in patients (pts) with relapsed/refractory multiple myeloma (RRMM): Initial results from the LINKER-MM2 trial
1个月前
已关闭
Pre-treatment with carfilzomib significantly improves response in R/R MM patients undergoing BCMA-directed CAR T cell therapy
1个月前
已关闭
T-cell engager activity of etentamig (BCMA x CD3) is potentiated by daratumumab in preclinical models of multiple myeloma
1个月前
已关闭
Preclinical Activity of JNJ-7957, a Novel BCMA×CD3 Bispecific Antibody for the Treatment of Multiple Myeloma, Is Potentiated by Daratumumab
1个月前
已完结
Bortezomib enhances the efficacy of BCMA CAR-T therapy through up-regulating BCMA expression in myeloma cells
1个月前
已完结
Plasma cell leukemia
2个月前
已完结
Pathogenesis of systemic lupus erythematosus: risks, mechanisms and therapeutic targets
5个月前
已完结
New insights into the role of antinuclear antibodies in systemic lupus erythematosus
5个月前
已完结
皖公网安备34019202002308
